These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31971463)

  • 1. The emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease.
    Zou H; Zhu N; Li S
    Expert Opin Ther Targets; 2020 Feb; 24(2):147-153. PubMed ID: 31971463
    [No Abstract]   [Full Text] [Related]  

  • 2. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD26/dipeptidyl peptidase IV: a regulator of immune function and a potential molecular target for therapy.
    Aytac U; Dang NH
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Mar; 4(1):11-8. PubMed ID: 15032621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms.
    Lu HY; Huang CY; Shih CM; Lin YW; Tsai CS; Lin FY; Shih CC
    J Vasc Surg; 2017 Oct; 66(4):1217-1226.e1. PubMed ID: 27887857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
    Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
    Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Dipeptidyl Peptidase-4 in Atherosclerotic Cardiovascular Disease in Humans and Animals with Chronic Stress.
    Piao L; Li Y; Narisawa M; Shen X; Cheng XW
    Int Heart J; 2021 May; 62(3):470-478. PubMed ID: 33994495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
    Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy.
    Hasan AA; Hocher B
    J Mol Endocrinol; 2017 Jul; 59(1):R1-R10. PubMed ID: 28420715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DPP-4 inhibitors: a patent review (2012 - 2014).
    Costante R; Stefanucci A; Carradori S; Novellino E; Mollica A
    Expert Opin Ther Pat; 2015 Feb; 25(2):209-36. PubMed ID: 25482888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.
    Augustyns K; Bal G; Thonus G; Belyaev A; Zhang XM; Bollaert W; Lambeir AM; Durinx C; Goossens F; Haemers A
    Curr Med Chem; 1999 Apr; 6(4):311-27. PubMed ID: 10101215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.
    Thompson MA; Ohnuma K; Abe M; Morimoto C; Dang NH
    Mini Rev Med Chem; 2007 Mar; 7(3):253-73. PubMed ID: 17346218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
    Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
    Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.
    Korom S; De Meester I; Stadlbauer TH; Chandraker A; Schaub M; Sayegh MH; Belyaev A; Haemers A; Scharpé S; Kupiec-Weglinski JW
    Transplantation; 1997 May; 63(10):1495-500. PubMed ID: 9175816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.
    Ruiz P; Hao L; Zucker K; Zacharievich N; Viciana AL; Shenkin M; Miller J
    Transpl Immunol; 1997 Jun; 5(2):152-61. PubMed ID: 9269038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
    Buljevic S; Detel D; Pugel EP; Varljen J
    J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo modulation of CD26 (dipeptidyl peptidase IV) in the mouse: effects of polyreactive and monoreactive antibodies.
    Yamaguchi N; Plant C; Biancone L; Bachovchin W; McCluskey R; Andres G
    Transplantation; 1996 Oct; 62(7):973-85. PubMed ID: 8878393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
    Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (Prodipine).
    De Meester I; Belyaev A; Lambeir AM; De Meyer GR; Van Osselaer N; Haemers A; Scharpé S
    Biochem Pharmacol; 1997 Jul; 54(1):173-9. PubMed ID: 9296364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence.
    Perner F; Gyuris T; Rákóczy G; Sárváry E; Görög D; Szalay F; Kunos I; Szönyi L; Péterfy M; Takács L
    J Lab Clin Med; 1999 Jul; 134(1):56-67. PubMed ID: 10402060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.